Resistance Training While on GLP-1: A Clinical Guide

A patient on semaglutide for nine months came in for a maintenance visit weighing thirty-two pounds less than baseline. He looked smaller in the way that should have been a win — and was not. His DEXA showed he had lost almost twelve pounds of lean mass. His resting metabolic rate, measured indirectly through a calculated equation, had dropped roughly 180 calories per day. He was not lifting. He had told himself, when starting the medication, that he would "add the gym in once the weight came off." Nine months later, the weight was off, the muscle was gone with it, and the body composition he had accomplished was the body composition that predicts regain.

This is the case I think about every time a new patient sits down to start a GLP-1 medication and asks whether they "really need to lift." The answer is yes, and it is not a matter of aesthetics. Skeletal muscle is the metabolic engine that determines what your body can sustain at the new lower weight. Lose the muscle and the new weight is not stable.

What happens to muscle on GLP-1 without resistance training

The published data on body composition during GLP-1 weight loss tells a consistent story. Across the major semaglutide and tirzepatide trials, lean mass losses run between twenty-five and forty percent of total weight lost when the protocol does not include structured resistance training and adequate protein. That ratio is roughly double what you see with comparable weight loss from caloric restriction with appropriate protein and resistance work.

The reasons for the disproportionate muscle loss are mechanical and physiological. Mechanically, when the medication suppresses appetite to the point that the patient is eating significantly less, total protein intake usually drops with total intake. Most patients do not consciously protect protein when their hunger is gone — they just eat less of everything, and protein density per calorie drops. Physiologically, the absence of a mechanical loading stimulus during weight loss removes the signal that tells the body to retain skeletal muscle. Muscle is metabolically expensive tissue. The body does not maintain it without a reason.

Resistance training is that reason. The mechanical tension generated by lifting a meaningful load against gravity creates micro-trauma in muscle fibers that triggers the local satellite cell response and the systemic anabolic signaling — mTOR pathway activation, growth hormone pulses, IGF-1 — that says to the body, "this tissue is being used; do not break it down for amino acids."

Without that signal, even adequate protein intake produces only a partial muscle-sparing effect. Protein and lifting work together. Either alone is insufficient.

Why the metabolic math matters

Skeletal muscle accounts for approximately twenty percent of resting metabolic rate per kilogram. Adipose tissue accounts for roughly four percent per kilogram. When a patient loses ten pounds of muscle and ten pounds of fat — a not-uncommon ratio without resistance training — they have lost meaningfully more of the tissue that determines how many calories they can sustain at maintenance.

The downstream effect is what drives the regain pattern that GLP-1 critics often point to. A patient who loses thirty pounds with thirty percent of that being lean mass has a lower resting metabolic rate than a patient who loses thirty pounds with ten percent lean mass loss. When the medication is discontinued, or even at maintenance dosing, the patient with the larger muscle deficit has less metabolic room before they start gaining. This is the mechanism behind a meaningful share of post-GLP-1 weight regain.

The patients who hold their weight loss long-term, in my practice, are not the ones who lost the most weight fastest. They are the ones who lost weight with a body composition trajectory that preserved or built lean mass alongside the fat loss. That outcome requires resistance training during the active loss phase, not after it.

What I program for patients on GLP-1

The exercise prescription I write for patients in the medical weight loss program is simpler than most patients expect. The variable that determines outcome is not the sophistication of the program. It is consistency, intensity, and presence of the major compound movements over time.

The framework I use:

• Two to three resistance sessions per week, spaced at least 48 hours apart for any given muscle group
• Compound movements as the foundation — squat or leg press pattern, hinge or deadlift pattern, horizontal push (bench press or pushup), horizontal pull (row), vertical push (overhead press), vertical pull (pull-up or lat pulldown)
• Two to four working sets per movement at a load that produces meaningful effort by the last few reps
• Rep ranges that drive hypertrophy — typically six to twelve reps per working set, with progressive overload tracked over weeks
• Progression by adding load, reps, or sets across sessions — not by changing exercises constantly

For a patient who has not lifted in years or who has never lifted, the first six to eight weeks are spent learning movement patterns at submaximal load. Form takes priority over intensity in this phase. After that, the load progresses incrementally, and the program runs essentially the same way for the duration of the GLP-1 course.

I do not program complex periodization for most weight loss patients. I do not program volume that requires four to five sessions a week. I program two to three sessions of compound movements with progressive overload because that is what the patient will actually do consistently for six to twelve months. A program that is theoretically optimal but that the patient will not adhere to produces zero result.

The other thing that matters: walking

Resistance training is non-negotiable for muscle preservation. Walking is a separate prescription that handles a different physiology. I want patients on GLP-1 walking eight to ten thousand steps a day not for caloric burn — the contribution is modest — but for insulin sensitivity, cardiovascular function, mood regulation, and the simple fact that sedentary behavior is independently catabolic to muscle even with adequate protein and lifting.

Walking and lifting are not interchangeable. The walker who never lifts still loses meaningful muscle on GLP-1. The lifter who sits otherwise misses the cardiometabolic adaptations the loss phase needs. I prescribe both.

What I look for at the three-month reassessment

The three-month reassessment is where the program either confirms it is working or shows me what to adjust. The data points I run:

• DEXA body composition — the only honest measure of fat mass versus lean mass change. Total weight loss with disproportionate lean loss is a flag to address before it gets worse.
• Strength progression — the patient who is gaining strength on their major lifts is not losing meaningful muscle, regardless of what the scale says
• Daily protein intake — measured for at least three days, not estimated
• Resistance training adherence — sessions actually completed in the prior month, not sessions scheduled
• Hormone re-check where indicated — for women in perimenopause, declining estrogen and testosterone affect both muscle preservation and recovery from training; hormone optimization running in parallel often makes the difference

If the composition trajectory is off, the most common adjustment is mechanical. Either protein intake has drifted below target, or training adherence has slipped, or both. We rebuild the structure and re-measure at the next visit.

Who is at highest risk for muscle loss on GLP-1

Some patients are at meaningfully higher risk for accelerated muscle loss during GLP-1 weight loss and need a more aggressive plan from day one. The flags I pay attention to:

• Women in perimenopause or menopause — declining estrogen and testosterone are independently catabolic to muscle
• Men with documented low testosterone — same physiology
• Patients over 60 — sarcopenia is already in progress and rapid weight loss accelerates it
• Patients with prior weight-cycling history — repeated cycles tend to disproportionately reduce lean mass
• Patients with very poor baseline fitness or strength — less existing muscle to lose means less buffer
• Patients with poor sleep architecture — growth hormone and testosterone are released during slow-wave sleep; disruption reduces the recovery and repair signaling that supports muscle maintenance

For patients in any of these categories, I am more aggressive about building the protein and training plan from the start. For perimenopausal women specifically, the hormone optimization conversation belongs in the same visit as the GLP-1 conversation, not as an afterthought. The two interventions support each other, and the patient who optimizes both ends a year on GLP-1 with stronger baseline composition than they started with — not just smaller.

How [nutritional counseling](/services/nutritional-counseling) ties this together

The protein structure that supports resistance training during GLP-1 weight loss is not intuitive. Most patients on GLP-1 default to soft, low-density foods because everything else "feels heavy." That pattern produces a daily protein intake of forty to sixty grams, which is well below what the training stimulus requires.

The nutritional plan I build for patients on GLP-1 with active resistance training targets 1.4 to 1.8 grams of protein per kilogram of reference body weight, distributed across three meals at thirty-five to forty-five grams each. For most patients that means the meal structure has to be planned, not improvised. We work through what they will actually eat, identify the convenience options that fit their schedule, and build the day around the protein anchors.

The concrete next step

If you are already on a GLP-1 medication and you are not lifting, that is the variable to change first. Two sessions a week of compound movements, with attention to form and progressive load, will do more for your long-term outcome than any further dose adjustment to the medication. If you do not have access to a gym, a basic barbell or dumbbell setup at home covers everything that matters.

If you are considering starting GLP-1 therapy, build the training and protein plan into the program from day one — not month four. At the Columbus clinic and the Warner Robins clinic, the workup for new GLP-1 patients includes a baseline composition assessment when indicated, a protein and training discussion, and a plan that treats muscle preservation as a primary outcome alongside weight loss.

Book through the online booking portal and bring your current training history, whatever it is. Even "I have not lifted in fifteen years" is useful information. From there I can build a program you will actually do for the duration of the medication course. That is what determines whether the year on GLP-1 produces a leaner stronger version of you or a smaller version of the same problem you started with.

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall (762) 261-3880

About Travis →More articles →Rebuild Institute →